Cargando…

Decreased TCF1 and BCL11B expression predicts poor prognosis for patients with chronic lymphocytic leukemia

T cell immune dysfunction is a prominent characteristic of chronic lymphocytic leukemia (CLL) and the main cause of failure for immunotherapy and multi-drug resistance. There remains a lack of specific biomarkers for evaluating T cell immune status with outcome for CLL patients. T cell factor 1 (TCF...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Taotao, Wang, Xiaojiao, Liu, Yanyan, Ai, Hao, Wang, Qian, Wang, Xianwei, Wei, Xudong, Song, Yongping, Yin, Qingsong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539190/ https://www.ncbi.nlm.nih.gov/pubmed/36211334 http://dx.doi.org/10.3389/fimmu.2022.985280

Ejemplares similares

The different predictive effects of the intensity and proportion of CD20 expression on the prognosis of B‐lineage acute lymphocyte leukemia
por: Tian, Yun, et al.
Publicado: (2022)

Effects of ibrutinib on T-cell immunity in patients with chronic lymphocytic leukemia
por: Liu, Yanyan, et al.
Publicado: (2022)

The CXCR4 Antagonist, AMD3100, Reverses Mesenchymal Stem Cell-Mediated Drug Resistance in Relapsed/Refractory Acute Lymphoblastic Leukemia
por: Wang, Shan, et al.
Publicado: (2020)

High Expression of BCL11A Predicts Poor Prognosis for Childhood MLL-r ALL
por: Wang, Lu-Lu, et al.
Publicado: (2021)

Fbxw11 promotes the proliferation of lymphocytic leukemia cells through the concomitant activation of NF-κB and β-catenin/TCF signaling pathways
por: Wang, Lina, et al.
Publicado: (2018)

Decreased deformability of lymphocytes in chronic lymphocytic leukemia
por: Zheng, Yi, et al.
Publicado: (2015)

Nuclear expression of TCF4/TCF7L2 is correlated with poor prognosis in patients with esophageal squamous cell carcinoma
por: Ishiguro, Hideyuki, et al.
Publicado: (2016)

Decreased calpain 6 expression is associated with tumorigenesis and poor prognosis in HNSCC
por: Xiang, Yinzhou, et al.
Publicado: (2017)

Decreased Lymphocyte-to-Monocyte Ratio Predicts Poor Prognosis of Acute Ischemic Stroke Treated with Thrombolysis
por: Ren, Hao, et al.
Publicado: (2017)

Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma
por: Shi, Lihui, et al.
Publicado: (2016)

Decreased Expression of Beclin 1 Correlates Closely with Bcl-xL Expression and Poor Prognosis of Ovarian Carcinoma
por: Lin, Huan-Xin, et al.
Publicado: (2013)

Decreased peripheral CD4(+)/CD8(+ )lymphocytes and poor prognosis in aged sepsis
por: Inoue, S, et al.
Publicado: (2012)

Low BCL7A expression predicts poor prognosis in ovarian cancer
por: Sun, Ziqian, et al.
Publicado: (2019)

Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker
por: Johansson, Patricia, et al.
Publicado: (2022)

Somatic MED12 mutations are associated with poor prognosis markers in chronic lymphocytic leukemia
por: Kämpjärvi, Kati, et al.
Publicado: (2014)

Underexpression of LINC00173 in TCF3/PBX1-Positive Cases Is Associated With Poor Prognosis in Children With B-Cell Precursor Acute Lymphoblastic Leukemia
por: May-Hau, Didier Ismael, et al.
Publicado: (2022)

BCL11A Is Oncogenic and Predicts Poor Outcomes in Natural Killer/T-Cell Lymphoma
por: Shi, Hongyun, et al.
Publicado: (2020)

Aberrant histone modification in CD19(+) B cells of patients with chronic lymphocytic leukemia
por: Zhou, Keshu, et al.
Publicado: (2017)

BCL10-CARD11 Fusion Mimics an Active CARD11 Seed That Triggers Constitutive BCL10 Oligomerization and Lymphocyte Activation
por: Seeholzer, Thomas, et al.
Publicado: (2018)

Bcl11b drives the birth of ILC2 innate lymphocytes
por: Zhong, Chao, et al.
Publicado: (2015)

Poor Prognosis in Acute Myeloid Leukemia Patients with Monosomal Karyotypes
por: Xu, Junqing, et al.
Publicado: (2017)

Poor Prognosis of Gastric Adenocarcinoma with Decreased Expression of AHRR
por: Li, Yuan-fang, et al.
Publicado: (2012)

Trisomy 11 as an Additional Chromosome Alteration in a Child with Acute Promyelocytic Leukemia with Poor Prognosis
por: Bastos, Elenice Ferreira, et al.
Publicado: (2012)

Publisher Correction: Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker
por: Johansson, Patricia, et al.
Publicado: (2023)

Functional characterization of common BCL11B gene desert variants suggests a lymphocyte-mediated association of BCL11B with aortic stiffness
por: Maskari, Raya Al, et al.
Publicado: (2018)

Bcl-2 expression is a poor predictor for hepatocellular carcinoma prognosis of andropause-age patients
por: Zhang, Xiao-Fei, et al.
Publicado: (2016)

Prognosis Factors in Chronic Lymphocytic Leukemia
por: Ivanescu, AM, et al.
Publicado: (2012)

High PGAM5 expression induces chemoresistance by enhancing Bcl-xL-mediated anti-apoptotic signaling and predicts poor prognosis in hepatocellular carcinoma patients
por: Cheng, Jingjing, et al.
Publicado: (2018)

Nuclear LEF1/TCF4 correlate with poor prognosis but not with nuclear β-catenin in cerebral metastasis of lung adenocarcinomas
por: Bleckmann, A., et al.
Publicado: (2012)

Chromosomal rearrangement involving 11q23 locus in chronic myelogenous leukemia: a rare phenomenon frequently associated with disease progression and poor prognosis
por: Wang, Wei, et al.
Publicado: (2015)

Decreased Expression of ZWINT is Associated With Poor Prognosis in Patients With HCC After Surgery
por: Yang, Xiao-Yu, et al.
Publicado: (2018)

Erratum to Bcl-2 expression is a poor predictor for hepatocellular carcinoma prognosis of andropause-age patients
por: Zhang, Xiao-Fei, et al.
Publicado: (2017)

BCL11B expression in hepatocellular carcinoma relates to chemosensitivity and clinical prognosis
por: Abe, Hiroyuki, et al.
Publicado: (2023)

Preferential linkage of bcl-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia
Publicado: (1990)

Decreased CRHBP expression is predictive of poor prognosis in patients with hepatocellular carcinoma
por: Xia, Hai-Bing, et al.
Publicado: (2018)

Overexpression of MYC and BCL2 Predicts Poor Prognosis in Patients with Extranodal NK/T-cell Lymphoma, Nasal Type
por: Wang, Jing-hua, et al.
Publicado: (2017)

PB1918: HIGH BAX/BCL-2 RATIO IS ASSOCIATED WITH GOOD PROGNOSIS AND BETTER SURVIVAL IN PATIENTS WITH B CELL CHRONIC LYMPHOCYTIC LEUKEMIA
por: Helaly, Nesrine
Publicado: (2023)

Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

The long noncoding RNA, treRNA, decreases DNA damage and is associated with poor response to chemotherapy in chronic lymphocytic leukemia
por: Miller, Cecelia R., et al.
Publicado: (2017)

Activated Allogeneic NK Cells Preferentially Kill Poor Prognosis B-Cell Chronic Lymphocytic Leukemia Cells
por: Sánchez-Martínez, Diego, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rb6lue1rgruo7sf3754o0lli63